Warberg Asset Management’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Warberg Asset Management’s Portfolio RVMDW Stock Details RVMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.08M	Hold	94,797	–	–	0.14%	54
2026 Q2	$889K	Buy	+94,797	New	+$513K	0.16%	53

Other funds holding RVMDW

Sculptor Capital New York $10.4B AUM 27.51% 1-Year Est. Return

Bleichroeder LP New York $1.02B AUM 33% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $116B AUM 33.19% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return

Warberg Asset Management's RVMDW Position: Q3 2026 in Review

Warberg Asset Management held its Revolution Medicines Inc Warrant (RVMDW) position steady in Q3 2026 at 94,797 shares worth $1.08M. The position accounts for 0.14% of the portfolio, ranked #54.

Warberg Asset Management first reported a position in RVMDW in Q2 2026 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold RVMDW as of Q3 2026.

Warberg Asset Management held 94,797 shares of Revolution Medicines Inc Warrant worth $1.08M as of Q3 2026.
Warberg Asset Management left its Revolution Medicines Inc Warrant share count unchanged in Q3 2026.
Revolution Medicines Inc Warrant made up 0.14% of Warberg Asset Management's portfolio in Q3 2026, its #54 holding.
Warberg Asset Management first reported a position in Revolution Medicines Inc Warrant in Q2 2026 and has held it in 2 quarters since.
8 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q3 2026.

Based on Warberg Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.